Loading provider…
Loading provider…
Hematology & Oncology Physician in Niagara Falls, NY
NPI: 1194722462Primary Employer
Mayo Clinic Jacksonville
mayoclinic.org
HQ Phone
Get MD Asher's Phone Numberphone_androidMobile
Get MD Asher's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
FL State Medical License
FL State Medical License
2011 - 2026
NY State Medical License
2002 - 2023
NJ State Medical License
1998 - 2003

American Board of Internal Medicine
Hematology
NYU Grossman School of Medicine
med.nyu.edu
Fellowship • Hematology and Medical Oncology
1999 - 2000
Fellowship • Hematology and Medical Oncology
1998 - 1999
Fellowship • Hematology and Medical Oncology
1997 - 1998
Harlem Hospital Center
Residency • Internal Medicine
1994 - 1997
Allama Iqbal Medical College
Medical School
Until 1993
Clinical roundtable monograph. New alternatives in CLL therapy: managing adverse events.
Authors: Thomas Kipps
Journal: Clin Adv Hematol Oncol
Authors: Robert Mc Williams, Aaron Mansfield, Grzegorz Nowakowski, Michaela Banck, Steven Robinson, Alan Bryce, Stephen Ansell
Journal: Oncotarget
IAP antagonists induce anti-tumor immunity in multiple myeloma.
Authors: Craig Reeder, Morie Gertz, David Dingli, Francis Buadi, Shaji Kumar, Peter Bergsagel, Rafael Fonseca, Yi Lin, Sikander Ailawadhi, Martha Lacy, Angela Dispenzieri
Journal: Nat Med
Publication Date: 2016-11-14
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Ixazomib Citrate, DRUG: Ibrutinib, OTHER: Pharmacokinetic Study, OTHER: Pharmacodynamic Study
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, OTHER: Pharmacological Study, DRUG: Lenalidomide, DRUG: Dexamethasone, DRUG: R-(-)-Gossypol Acetic Acid
Lead Sponsor: Mayo Clinic
Intervention / Treatment: OTHER: Laboratory Biomarker Analysis, DRUG: Ibrutinib